Concise review: Embryonic stem cells: A new tool to study osteoblast and osteoclast differentiation

Stem Cells

Volumn 25, Issue 3, 2007, Pages 544-552

  Duplomb, Laurence ^a,b,d   Dagouassat, Maylis ^c   Jourdon, Philippe ^c   Heymann, Dominique ^a,b  

^a Universite de Nantes   (France)

^b L INSTITUT DU THORAX   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d INSERM   (France)

Author keywords

Embryoid bodies; Embryonic stem cells; Osteoblasts; Osteoclasts

Indexed keywords

ALKALINE PHOSPHATASE; ASCORBIC ACID; CALCITRIOL; COLECALCIFEROL; COLLAGEN TYPE 1; GLYCEROL 2 PHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCALCIN; TARTRATE RESISTANT ALKALINE PHOSPHATASE; UNCLASSIFIED DRUG;

BONE DISEASE; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL SUSPENSION; EMBRYONIC STEM CELL; HUMAN; IN VITRO STUDY; NONHUMAN; OSTEOBLAST; OSTEOCLAST; REVIEW;

BONE AND BONES; BONE DISEASES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; OSTEOBLASTS;

EID: 33847653428     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0395     Document Type: Review

References (122)

1. Aguila HL, Rowe DW. Skeletal development, bone remodeling, and hematopoiesis. Immunol Rev 2005;208:7-18.
2. Rousselle AV, Heymann D. Osteoclastic acidification pathways during bone resorption. Bone 2002;30:533-540.
3. Aubin JE, Triffit JT. Mesenchymal stem cells and osteoblast differentiation. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. Vol. 1. San Diego: Academic Press, 2002:59-81.
4. Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol 2000;192:4-13.
5. Roodman GD. Regulation of osteoclast differentiation. Ann N Y Acad Sci 2006;1068:100-109.
6. Epker BN, Frost HM. Correlation of bone resorption and formation with the physical behavior of loaded bone. J Dent Res 1965;44:33-41.
7. Ilvesaro J, Tuukkanen J. Gap-junctional regulation of osteoclast function. Crit Rev Eukaryot Gene Expr 2003;13:133-146.
8. Heymann D, Guicheux J, Gouin F et al. Cytokines, growth factors and osteoclasts. Cytokine 1998;10:155-168.
9. Theoleyre S, Wittrant Y, Tat SK et al. The molecular triad OPG/RANK/RANKL: Involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004;15:457-475.
10. Blair HC, Zaidi M, Schlesinger PH. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J 2002;364:329-341.
11. Ishimi Y, Miyaura C, Jin CH et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-3303.
12. Marie PJ, Hott M, Launay JM et al. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: Relationship with cell proliferation. J Clin Endocrinol Metab 1993;77:824-830.
13. Lowik CW, van der Pluijm G, Bloys H et al. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 1989;162:1546-1552.
14. Liu XH, Kirschenbaum A, Yao S et al. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK) ligand/RANK system. Endocrinology 2005;146:1991-1998.
15. Filanti C, Dickson GR, Di Martino D et al. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J Bone Miner Res 2000;15:2154-2168.
16. Uchida M, Shima M, Shimoaka T et al. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol 2000;185:207-214.
17. Franz-Odendaal TA, Hall BK, Witten PE. Buried alive: How osteoblasts become osteocytes. Dev Dyn 2006;235:176-190.
18. Sudo H, Kodama HA, Amagai Y et al. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983;96:191-198.
19. Kurihara N, Ikeda K, Hakeda Y et al. Effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity and collagen synthesis in osteoblastic cells, clone MC3T3-E1. Biochem Biophys Res Commun 1984;119:767-771.
20. Kim SW, Her SJ, Park SJ et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 2005;37:359-369.
21. Nielsen LB, Pedersen FS, Pedersen L. Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone 2001;28:160-166.
22. Oshima K, Nampei A, Matsuda M et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005;331:520-526.
23. Guicheux J, Lemonnier J, Ghayor C et al. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 2003;18:2060-2068.
24. Boden SD, McCuaig K, Hair G et al. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 1996;137:3401-3407.
25. Declercq H, Van den Vreken N, De Maeyer E et al. Isolation, proliferation and differentiation of osteoblastic cells to study cell/biomaterial interactions: Comparison of different isolation techniques and source. Biomaterials 2004;25:757-768.
26. Ikedo D, Ohishi K, Yamauchi N et al. Stimulatory effects of phenytoin on osteoblastic differentiation of fetal rat calvaria cells in culture. Bone 1999;25:653-660.
27. Johnson KA, Hessle L, Vaingankar S et al. Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 2000;279:R1365-R1377.
28. Bi Y, Nielsen KL, Kilts TM et al. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 2006;38:778-786.
29. Hattori H, Sato M, Masuoka K et al. Osteogenic potential of human adipose tissue-derived stromal cells as an alternative stem cell source. Cells Tissues Organs 2004;178:2-12.
30. Lee RH, Kim B, Choi I et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-324.
31. Fukuchi Y, Nakajima H, Sugiyama D et al. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. STEM CELLS 2004;22:649-658.
32. Alsalameh S, Amin R, Gemba T et al. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 2004;50:1522-1532.
33. Bruder SP, Kurth AA, Shea M et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-162.
34. Wang Z, Goh J, Das De S et al. Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng 2006;12:1753-1761.
35. Toquet J, Rohanizadeh R, Guicheux J et al. Osteogenic potential in vitro of human bone marrow cells cultured on macroporous biphasic calcium phosphate ceramic. J Biomed Mater Res 1999;44:98-108.
36. Bohic S, Rohanizadeh R, Touchais S et al. Leukemia inhibitory factor and oncostatin M influence the mineral phases formed in a murine heterotopic calcification model: A Fourier transform-infrared microspectroscopic study. J Bone Miner Res 1998;13:1619-1632.
37. Bonab MM, Alimoghaddam K, Talebian F et al. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006;7:14.
38. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
39. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166.
40. Jaiswal N, Haynesworth SE, Caplan AI et al. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997;64:295-312.
41. Olivier EN, Rybicki AC, Bouhassira EE. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. STEM CELLS 2006;24:1914-1922.
42. Buttery LD, Bourne S, Xynos JD et al. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 2001;7:89-99.
43. Kawaguchi J, Mee PJ, Smith AG. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 2005;36:758-769.
44. Cheng SL, Yang JW, Rifas L et al. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 1994;134:277-286.
45. zur Nieden NI, Kempka G, Ahr HJ. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 2003;71:18-27.
46. zur Nieden NI, Kempka G, Rancourt DE et al. Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: Effect of cofactors on differentiating lineages. BMC Dev Biol 2005;5:1.
47. Phillips BW, Belmonte N, Vernochet C et al. Compactin enhances osteogenesis in murine embryonic stem cells. Biochem Biophys Res Commun 2001;284:478-484.
48. Bronson SK. Bone nodule formation via in vitro differentiation of murine embryonic stem cells. Methods Enzymol 2003;365:241-251.
49. Bain G, Kitchens D, Yao M et al. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995;168:342-357.
50. Dani C, Smith AG, Dessolin S et al. Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci 1997;110:1279-1285.
51. Choi JY, Lee BH, Song KB et al. Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells. J Cell Biochem 1996;61:609-618.
52. Yamaguchi A, Katagiri T, Ikeda T et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991;113:681-687.
53. Kramer J, Hegert C, Guan K et al. Embryonic stem cell-derived chondrogenic differentiation in vitro: Activation by BMP-2 and BMP-4. Mech Dev 2000;92:193-205.
54. Valta MP, Hentunen T, Qu Q et al. Regulation of osteoblast differentiation: A novel function for fibroblast growth factor 8. Endocrinology 2006;147:2171-2182.
55. Karp JM, Ferreira LS, Khademhosseini A et al. Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. STEM CELLS 2006;24:835-843.
56. Sottile V, Thomson A, McWhir J. In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 2003;5:149-155.
57. Cao T, Heng BC, Ye CP et al. Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of morphologically distinct nodule-like structures. Tissue Cell 2005;37:325-334.
58. Ahn SE, Kim S, Park KH et al. Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun 2006;340:403-408.
59. Barberi T, Willis LM, Socci ND et al. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2005;2:e161.
60. Yamashita A, Takada T, Narita J et al. Osteoblastic differentiation of monkey embryonic stem cells in vitro. Cloning Stem Cells 2005;7:232-237.
61. Fuller K, Chambers TJ. Generation of osteoclasts in cultures of rabbit bone marrow and spleen cells. J Cell Physiol 1987;132:441-452.
62. Udagawa N, Takahashi N, Katagiri T et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 1995;182:1461-1468.
63. Nishikawa M, Akatsu T, Katayama Y et al. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone 1996;18:9-14.
64. Sabokbar A, Fujikawa Y, Brett J et al. Increased osteoclastic differentiation by PMMA particle-associated macrophages. Inhibitory effect by interleukin 4 and leukemia inhibitory factor. Acta Orthop Scand 1996;67:593-598.
65. O'Brien EA, Williams JH, Marshall MJ. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria. Biochem Biophys Res Commun 2000;274:281-290.
66. Tsurukai T, Udagawa N, Matsuzaki K et al. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. J Bone Miner Metab 2000;18:177-184.
67. Nicholson GC, Malakellis M, Collier FM et al. Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci (Lond) 2000;99:133-140.
68. Kudo O, Sabokbar A, Pocock A et al. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 2003;32:1-7.
69. Beeton CA, Bord S, Ireland D et al. Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone 2006;24:24.
70. Sorensen MG, Henriksen K, Dziegiel MH et al. Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption by mature osteoclasts. DNA Cell Biol 2006;25:475-483.
71. Atkins GJ, Kostakis P, Vincent C et al. RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 2006;21:1339-1349.
72. Wittrant Y, Theoleyre S, Couillaud S et al. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. Exp Cell Res 2004;293:292-301.
73. Tanaka S, Takahashi N, Udagawa N et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 1993;91:257-263.
74. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998;95:3597-3602.
75. Perkins SL, Kling SJ. Local concentrations of macrophage colony-stimulating factor mediate osteoclastic differentiation. Am J Physiol 1995;269:E1024-E1030.
76. Shih C, Bernard GW. Peripheral blood mononuclear cells develop into multinucleated osteoclasts in tissue culture. Anat Rec 1996;245:41-45.
77. Yamane T, Kunisada T, Yamazaki H et al. Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 1997;90:3516-3523.
78. Okuyama H, Tsuneto M, Yamane T et al. Discrete types of osteoclast precursors can be generated from embryonic stem cells. STEM CELLS 2003;21:670-680.
79. Hemmi H, Okuyama H, Yamane T et al. Temporal and spatial localization of osteoclasts in colonies from embryonic stem cells. Biochem Biophys Res Commun 2001;280:526-534.
80. Yamane T, Kunisada T, Yamazaki H et al. Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development. Exp Hematol 2000;28:833-840.
81. Tsuneto M, Yamazaki H, Yoshino M et al. Ascorbic acid promotes osteoclastogenesis from embryonic stem cells. Biochem Biophys Res Commun 2005;335:1239-1246.
82. Nakano T, Kodama H, Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 1994;265:1098-1101.
83. Nicholls BM, Bredius RG, Hamdy NA et al. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. J Bone Miner Res 2005;20:2264-2270.
84. Heymann D, Ory B, Gouin F et al. Bisphosphonates: New therapeutic agents for the treatment of bone tumors. Trends Mol Med 2004;10:337-343.
85. Alsberg E, Anderson KW, Albeiruti A et al. Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res 2001;80:2025-2029.
86. Hattersley G, Chambers TJ. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue. J Cell Physiol 1990;142:201-209.
87. Fischer EM, Layrolle P, Van Blitterswijk CA et al. Bone formation by mesenchymal progenitor cells cultured on dense and microporous hydroxyapatite particles. Tissue Eng 2003;9:1179-1188.
88. Oreffo RO, Driessens FC, Planell JA et al. Growth and differentiation of human bone marrow osteoprogenitors on novel calcium phosphate cements. Biomaterials 1998;19:1845-1854.
89. Yoshikawa H, Myoui A. Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs 2005;8:131-136.
90. Suzuki A, Raya A, Kawakami Y et al. Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci U S A 2006;103:10294-10299.
91. Nishimura R, Kato Y, Chen D et al. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 1998;273:1872-1879.
92. Ryoo HM, Lee MH, Kim YJ. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 2006;366:51-57.
93. Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998;139:1329-1337.
94. Tu Q, Valverde P, Chen J. Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem Biophys Res Commun 2006;341:1257-1265.
95. Deliloglu-Gurhan SI, Vatansever HS, Ozdal-Kurt F et al. Characterization of osteoblasts derived from bone marrow stromal cells in a modified cell culture system. Acta Histochem 2006;108:49-57.
96. van den Dolder J, Jansen JA. Enrichment of osteogenic cell populations from rat bone marrow stroma. Biomaterials 2007;28:249-255.
97. Ye CP, Heng BC, Liu H et al. Culture media conditioned by heat-shocked osteoblasts enhances the osteogenesis of bone marrow-derived mesenchymal stromal cells. Cell Biochem Funct 2006 [Epub ahead of print].
98. Kim SJ, Cho HH, Kim YJ et al. Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice. Biochem Biophys Res Commun 2005;329:25-31.
99. Malladi P, Xu Y, Yang GP et al. Functions of vitamin D, retinoic acid, and dexamethasone in mouse adipose-derived mesenchymal cells. Tissue Eng 2006;12:2031-2040.
100. Tholpady SS, Katz AJ, Ogle RC. Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. Anat Rec A Discov Mol Cell Evol Biol 2003;272:398-402.
101. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. STEM CELLS 2004;22:1338-1345.
102. Kurihara N, Ishizuka S, Kiyoki M et al. Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology 1986;118:940-947.
103. Chaudhry GR, Yao D, Smith A et al. Osteogenic cells derived from embryonic stem cells produced bone nodules in three-dimensional scaffolds. J Biomed Biotechnol 2004;2004:203-210.
104. Bourne S, Polak JM, Hughes SP et al. Osteogenic differentiation of mouse embryonic stem cells: Differential gene expression analysis by cDNA microarray and purification of osteoblasts by cadherin-11 magnetically activated cell sorting. Tissue Eng 2004;10:796-806.
105. Shimko DA, Burks CA, Dee KC et al. Comparison of in vitro mineralization by murine embryonic and adult stem cells cultured in an osteogenic medium. Tissue Eng 2004;10:1386-1398.
106. Bielby RC, Boccaccini AR, Polak JM et al. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 2004;10:1518-1525.
107. Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 2006;98:538-554.
108. Yang M, Mailhot G, Birnbaum MJ et al. Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis. J Biol Chem 2006;281:23598-23605.
109. Zou W, Amcheslavsky A, Takeshita S et al. TNF-alpha expression is transcriptionally regulated by RANK ligand. J Cell Physiol 2005;202:371-378.
110. Zhu LL, Zaidi S, Moonga BS et al. RANK-L induces the expression of NFATc1, but not of NFkappaB subunits during osteoclast formation. Biochem Biophys Res Commun 2005;326:131-135.
111. Barton BE, Mayer R. IL-3 induces differentiation of bone marrow precursor cells to osteoclast-like cells. J Immunol 1989;143:3211-3216.
112. Hattersley G, Chambers TJ. Calcitonin receptors as markers for osteoclastic differentiation: Correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology 1989;125:1606-1612.
113. Sasaki T, Takahashi N, Higashi S et al. Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1 alpha,25-dihydroxyvitamin D3 have ruffled borders and resorb dentine. Anat Rec 1989;224:379-391.
114. Takahashi N, Yamana H, Yoshiki S et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 1988;122:1373-1382.
115. Wei S, Kitaura H, Zhou P et al. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005;115:282-290.
116. Gan OI, Soueidan A, Castagne A et al. Rat long-term bone marrow culture as a model for transient production of multinucleated giant cells into suspension culture fraction and for steady mineralization process of adherent stromal cells. C R Acad Sci III 1994;317:324-331.
117. MacDonald BR, Takahashi N, McManus LM et al. Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures. Endocrinology 1987;120:2326-2333.
118. Thavarajah M, Evans DB, Kanis JA. 1,25(OH)2D3 induces differentiation of osteoclast-like cells from human bone marrow cultures. Biochem Biophys Res Commun 1991;176:1189-1195.
119. Komano Y, Nanki T, Hayashida K et al. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther 2006;8:R152.
120. Flanagan AM, Horton MA, Dorey EL et al. An assessment of the ability of human bone marrow cultures to generate osteoclasts. Int J Exp Pathol 1992;73:387-401.
121. Brage M, Lie A, Ransjo M et al. Osteoclastogenesis is decreased by cysteine proteinase inhibitors. Bone 2004;34:412-424.
122. Fuller K, Murphy C, Kirstein B et al. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002;143:1108-1118.